Sclerosing peritonitis;Péritonite sclérosante

Nephrologie

Volumn 22, Issue 4, 2001, Pages 141-148

  Michel, C ^a   Hufnagel, G ^a   Niang, A ^a   Shkiri, H ^a   Queffeulou, G ^a   Vrtovsnik, F ^a   Mignon, F ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Advanced glycosylation end products; Peritoneal dialysis; Sclerosing peritonitis; Ultrafiltration failure

Indexed keywords

CORTICOSTEROID;

ADULT; ASCITES; CASE REPORT; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CORTICOSTEROID THERAPY; GASTROINTESTINAL SYMPTOM; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY TRANSPLANTATION; PATHOPHYSIOLOGY; REVIEW; SCLEROSING PERITONITIS; SYMPTOMATOLOGY;

ADRENAL CORTEX HORMONES; ADULT; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; PERITONITIS;

EID: 0034945886     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. What really happens to people on long-term peritoneal dialysis?
2. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: A report of the japanese sclerosing encapsulating peritonitis study group
3. Sclerosing peritonitis: The experience in Australia
4. Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: One center's experience and review of the literature
5. Stability of the peritoneal membrane in long-term peritoneal dialysis patients
6. The peritoneal membrane in chronic peritoneal dialysis
7. Progressive sclerosing peritonitis: A late and severe complication of maintenance peritoneal dialysis
8. Peritoneal sclerosis in peritoneal dialysis patients: Analysis of clinical presentation, risk factors and peritoneal transport kinetics
9. Sclerosing peritonitis: Identification of diagnostic, clinical, and radiological features
10. Ultrasound changes in sclerosing peritonitis following continuous ambulatory peritoneal dialysis
11. Sclerosing peritonitis: Possible early diagnosis by computerized tomography of the abdomen
12. Prevention and treatment of peritoneal dialysis membrane failure
13. Evaluation of ultrafiltration failure
14. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity
15. Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis
16. Issues affecting the longevity of the continuous peritoneal dialysis therapy
17. Peritoneal physiology transport of solutes
18. Impact of surface area and permeability in solute clearances
19. Does impaired transcellular water transport contribute to net ultrafiltration failure during CAPD?
20. A 39-year old man with loss of ultrafiltration
21. Expression of aquaporin-1 in a long-term peritoneal dialysis patient with impaired transcellular water transport
22. Peritoneal fluid markers of mesothelial cells and function
23. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis
24. Atlas of peritoneal histology: Peritonitis
25. Preserving the peritoneal dialysis membrane in long-term peritoneal dialysis patients
26. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis
27. Sclerosing encapsulating peritonitis associated with continuous ambulatory peritoneal dialysis: Surgical management
28. Loss of ultrafiltration and sclerosing encapsulating peritonitis during CAPD. Evaluation of the potential risk factors
29. Immunosuppression in sclerosing peritonitis
30. A case of a dialysis patient with sclerosing peritonitis successfully treated by corticosteroid therapy alone
31. Sclerosing encapsulating peritonitis: A case successfully treated with immunosuppression
32. Sclerosing peritonitis: Value of immunosuppression prior to surgery
33. Pathogenesis of sclerosing peritonitis in CAPD
34. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients
35. Membrane longevity in peritoneal dialysis: Impact of infection and bio-incompatible solutions
36. Pasteurella multocida peritonitis in peritoneal dialysis
37. Immunohistochemical detection of advanced glycosylation end products in the peritoneum and its possible pathophysiological role in CAPD
38. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration
39. Neoangiogenesis in the peritoneal membrane
40. Vascular proliferation and exhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis
41. Strategies to reduce glucose exposure in peritoneal dialysis patients
42. Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure